The Shelley & Allan Holt Assistant Professor of Ophthalmology, Assistant Professor of Cellular and Molecular Medicine, Wilmer Eye Institute, Johns Hopkins UniversityBaltimore, MD
Dr. Johnson is a glaucoma specialist and a neuroscientist at the Johns Hopkins Wilmer Eye Institute. In addition to caring for patients with glaucoma, he leads a clinical research program that is investigating the use of remote eye pressuring monitoring to better understand intraocular pressure fluctuations in patients with glaucoma. In addition, he runs a translational research laboratory aimed and developing innovative therapies to slow or even reverse vision loss in glaucoma and other optic neuropathies. He is funded by grant awards from the National Eye Institute (NIH), Research to Prevent Blindness, The BrightFocus Foundation, the American Glaucoma Society, and the Zenkel Family Foundation. His research has been recognized with the NC3Rs Prize, a World Glaucoma Association Top-Ten papers designation, The NEI Scientific Director’s Award, The AFER/ARVO Merck Innovative Research Award, and the Douglas H Johnson Award (BrightFocus). He was recently designated by Ophthalmology Management as a “top 40 under 40” ophthalmologist.
Dr. Johnson is a strong advocate for identifying and preventing blindness in at-risk patients, including underserved and underrepresented members of our community. He founded and now serves as the Faculty Mentor for the Johns Hopkins Vision Screening In Our Neighborhoods (ViSION) program, and has been recognized for this work with the Reverend Melvin B Tuggle Community Excellence Award and AAO’s Artemis Award.
Dr. Johnson serves on the Association for Research in Vision and Ophthalmology’s (ARVO) Programming Committee and Advocacy & Outreach Committee, the American Glaucoma Society’s (AGS) Research Committee, Fight For Sight’s Scientific Review Board, and The Glaucoma Foundation’s Scientific Review Board. He is an associate editor for the American Academy of Ophthalmology’s journal Ophthalmology Science. He also serves as the Chairman of the Organizing Committee for the international Retinal Ganglion Cell Repopulation, Stem Cell Transplantation, and Optic Nerve Regeneration (RReSTORe) Consortium